Therapy Areas: Devices
Implantica submits final FDA response for RefluxStop PMA application
20 May 2026 - Medical technology company Implantica AG (Nasdaq First North Premier Growth Market: IMP A SDB) announced on Wednesday that it has submitted its final response to the US Food and Drug Adm...
Artivion completes acquisition of Endospan following FDA approval of NEXUS Aortic Arch System
18 May 2026 - Endospan, a pioneer in endovascular solutions for complex aortic pathologies, announced on Monday that it has been acquired by medical device company Artivion Inc (NYSE: AORT) following ...
AngioDynamics reports 24-month PRESERVE data showing durable NanoKnife outcomes in prostate cancer
13 May 2026 - Medical technology company AngioDynamics Inc (NASDAQ: ANGO) reported on Wednesday that the two-year results from the PRESERVE pivotal trial of its NanoKnife System demonstrated sustained...
Cepheid receives CE mark for IVDR‑compliant gastrointestinal PCR panel
Vector Science & Therapeutics secures three-year manufacturing partnership with MPP Group to expand peptide pipeline
11 May 2026 - Medical technology company Vector Science & Therapeutics (TSXV: PAIN) announced on Monday that it has entered a three-year development and manufacturing agreement with MPP Group LLC ...
Abingdon Health supports UK launch of LVOne stroke triage test
11 May 2026 - Abingdon Health plc (AIM: ABDX) (OTCQB: ABDXF) reported on Monday that its customer UpFront Diagnostics has commercially launched the LVOne stroke triage blood test in the UK following U...